Academic Journal

Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer.

التفاصيل البيبلوغرافية
العنوان: Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer.
المؤلفون: Nakatsuma, Kenji, Ozasa, Neiko, Ohno, Mikiko, Ishiguro, Hiroshi, Minami, Manabu, Nishi, Eiichiro, Toi, Masakazu, Ono, Koh, Kimura, Takeshi
المصدر: Journal of Cardiology; Oct2024, Vol. 84 Issue 4, p260-265, 6p
مستخلص: Data on the incidence, timing, and severity of myocardial damage after anthracycline-based chemotherapy (AC) in Japanese patients with breast cancer are limited. We evaluated cancer therapy-related cardiac dysfunction (CTRCD) in Japanese women with breast cancer (n = 51) after the first AC according to the definitions of the 2022 European Society of Cardiology onco-cardiology guideline, including assessment of high-sensitivity troponin I (TnI) and B-type natriuretic peptide (BNP) levels. CTRCD was detected in 67 % of the patients (3.9 %, 7.8 %, 9.8 %, 43 %, 37 %, 22 %, 20 %, and 9.8 % of patients at 1 week and 1, 2, 3, 6, 9, 12, and 15 months post-AC, respectively) without significant left ventricular ejection fraction reduction (<50 %) and heart failure. Elevated TnI levels (>26 pg/mL) were found in 43 % of patients, and elevated BNP levels (≥35 pg/mL) were observed in 22 % of patients during the follow-up period. Approximately two-thirds of the Japanese patients in this study experienced CTRCD, which was frequently observed at 3 or 6 months post-AC. However, all patients with CTRCD were diagnosed with mild asymptomatic CTRCD. Although, these patients were diagnosed with mild asymptomatic CTRCD, careful long-term follow-up will be required. [Display omitted] • Two-thirds of the Japanese patients experienced cancer therapy-related cardiac dysfunction (CTRCD). • CTRCD was frequently observed at 3 or 6 months post-anthracycline-based chemotherapy. • All patients with CTRCD were diagnosed with mild asymptomatic CTRCD. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Cardiology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:09145087
DOI:10.1016/j.jjcc.2024.03.005